Št. zadetkov: 21
Diplomsko delo
Oznake:
overjanje;biometrija;prepoznavanje obrazov;prstni odtisi;
Diplomsko delo predstavlja pregled glavnih overitvenih pristopov za osebno uporabo. Najprej smo opisali osnovne koncepte overjanja ter obravnavali tri glavne načine overjanja: kaj nekdo ve, kaj nekdo je in kaj nekdo ima. Predstavili smo tudi prednosti in slabosti teh metod in raziskali, katera je na ...
Leto:
2013
Vir:
Fakulteta za elektrotehniko, računalništvo in informatiko (UM FERI)
Izvirni znanstveni članek
Oznake:
dog;nerve sheath tumor;immunohistochemistry;methylation;H3K27me3;nerve sheath neoplasms;
Nerve sheath tumors (NSTs) are characterized by neoplastic proliferation of Schwann cells, perineurial cells, endoneurial and/or epineurial fibroblasts. Diagnosis of NST is often challenging, particularly in distinguishing malignant NST (MNST) from other soft tissue sarcomas, or sometimes between lo ...
Leto:
2022
Vir:
Veterinarska fakulteta (UL VF)
Objavljeni znanstveni prispevek na konferenci
Oznake:
tekočinska biopsija;onkološko zdravljenje;možganski tumorji;
Minimalno invazivni diagnostični pristopi pri primarnih možganskih tumorjih z uporabo prosto cirkulirajočih nukleinskih kislin
Leto:
2021
Vir:
Onkološki inštitut Ljubljana (OI)
Izvirni znanstveni članek
Oznake:
glioblastoma;stem cells;nanobodies;cell migration;citotoxicity;vimentin;DPYSL2;NAP1L1;TUFM;
Background: Glioblastoma is a particularly common and very aggressive primary brain tumour. One of the main causes of therapy failure is the presence of glioblastoma stem cells that are resistant to chemotherapy and radiotherapy, and that have the potential to form new tumours. This study focuses on ...
Leto:
2020
Vir:
Medicinska fakulteta (UL MF)
Izvirni znanstveni članek
Oznake:
glioblastoma;malignancy;FREM2;SPRY1;TCGA;
World Health Organization grade IV diffuse gliomas, known as glioblastomas, are the most common malignant brain tumors, and they show poor prognosis. Multimodal treatment of surgery followed by radiation and chemotherapy is not sufficient to increase patient survival, which is 12 to 18 months after ...
Leto:
2019
Vir:
Medicinska fakulteta (UL MF)
Objavljeni povzetek znanstvenega prispevka na konferenci
Oznake:
glioblastom;organoidi;standardna terapija;model ex vivo;biologija raka;
Organoidi glioblastoma razkrivajo odpornost na standardno terapijo
Leto:
2023
Vir:
Nacionalni inštitut za biologijo (NIB)
Barbara Breznik,
Bernarda Majc,
Anamarija Habič,
Urška Ušeničnik,
Andrej Porčnik,
Roman Bošnjak,
Jernej Mlakar,
Marija Skoblar Vidmar,
Tanja Dolinšek,
Maja Čemažar,
Tamara Lah Turnšek,
Metka Novak
Objavljeni znanstveni prispevek na konferenci (vabljeno predavanje)
Oznake:
glioblastom;mikrookolje;organoidi;možganski rak;možganski tumor;onkologija;
Glioblastom je najpogostejši možganski tumor pri odraslih z zelo slabo prognozo preživetja bolnikov. Ta je posledica odpornosti glioblastoma na standardno zdravljenje, ki vključuje radioterapijo in kemoterapijo. Z namenom načrtovanja učinkovitejših pristopov zdravljenja preučujemo biološke mehanizme ...
Leto:
2022
Vir:
Nacionalni inštitut za biologijo (NIB)
Tomaž Rus,
Jernej Mlakar,
Luka Ležaič,
An Vo,
Nha Nguyen,
Chris Chengke Tang,
Michele Fiorini,
Elena Prieto,
Gloria Martí Andrés,
Javier Arbizu,
David Eidelberg,
Maja Trošt
Izvirni znanstveni članek
Oznake:
nevrologija;Creutzfeldt-Jakobova bolezen;
Background and purpose: Although sporadic Creutzfeldt–Jakob disease (sCJD) is a rare cause of dementia, it is critical to understand its functional networks as the prion protein spread throughout the brain may share similar mechanisms with other more common neurodegenerative disorders. In this study ...
Leto:
2022
Vir:
Medicinska fakulteta (UL MF)
Maxim Sorokin,
Mikhail Raevskiy,
Alja Zottel,
Neja Zupanec,
Marija Skoblar Vidmar,
Alenka Matjašič,
Andrej Zupan,
Jernej Mlakar,
Maria Suntsova,
Denis V. Kuzmin,
Anton A. Buzdin,
Ivana Jovchevska
Izvirni znanstveni članek
Oznake:
glioblastom;nekodirajoča RNA;dolgoročno preživetje;glioblastoma;noncoding RNA;long-term survival;
Glioblastoma is the most common and malignant brain malignancy worldwide, with a 10-year survival of only 0.7%. Aggressive multimodal treatment is not enough to increase life expectancy and provide good quality of life for glioblastoma patients. In addition, despite decades of research, there are no ...
Leto:
2021
Vir:
Medicinska fakulteta (UL MF)
Metka Novak,
Miha Koprivnikar Krajnc,
Barbara Hrastar,
Barbara Breznik,
Bernarda Majc,
Mateja Mlinar,
Ana Rotter,
Andrej Porčnik,
Jernej Mlakar,
Katja Stare,
Richard G. Pestell,
Tamara Lah Turnšek
Izvirni znanstveni članek
Oznake:
glioblastom;kemokini;tumorsko mikrookolje;invazija;CCL5;CCR5;chemokines;glioblastoma;invasion;maraviroc;mesenchymal stem cells;
The chemokine CCL5/RANTES is a versatile inflammatory mediator, which interacts with the receptor CCR5, promoting cancer cell interactions within the tumor microenvironment. Glioblastoma is a highly invasive tumor, in which CCL5 expression correlates with shorter patient survival. Using immunohistoc ...
Leto:
2020
Vir:
Medicinska fakulteta (UL MF)